BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12754200)

  • 1. Farnesoid X receptor regulates bile acid-amino acid conjugation.
    Pircher PC; Kitto JL; Petrowski ML; Tangirala RK; Bischoff ED; Schulman IG; Westin SK
    J Biol Chem; 2003 Jul; 278(30):27703-11. PubMed ID: 12754200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner.
    Kanaya E; Shiraki T; Jingami H
    Biochem J; 2004 Sep; 382(Pt 3):913-21. PubMed ID: 15202934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
    Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
    J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Short Review on Obeticholic Acid: An Effective Modulator of Farnesoid X Receptor.
    Narayanan AK; Surendran S; Balakrishnan D; Gopalakrishnan U; Malick S; Valsan A; Philips CA; Watson CJE
    Curr Rev Clin Exp Pharmacol; 2024; 19(3):225-233. PubMed ID: 38708917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids and their signaling pathways: eclectic regulators of diverse cellular functions.
    Scotti E; Gilardi F; Godio C; Gers E; Krneta J; Mitro N; De Fabiani E; Caruso D; Crestani M
    Cell Mol Life Sci; 2007 Oct; 64(19-20):2477-91. PubMed ID: 17876519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activation.
    Sun AQ; Luo Y; Backos DS; Xu S; Balasubramaniyan N; Reigan P; Suchy FJ
    Mol Pharmacol; 2013 May; 83(5):1078-86. PubMed ID: 23462506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP.
    Fang S; Tsang S; Jones R; Ponugoti B; Yoon H; Wu SY; Chiang CM; Willson TM; Kemper JK
    J Biol Chem; 2008 Dec; 283(50):35086-95. PubMed ID: 18842595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of hepatocyte cysteine dioxygenase type 1, a bile acid repressed gene, enhances glutathione synthesis and ameliorates acetaminophen hepatotoxicity.
    Chen J; Matye D; Dai Clayton Y; Du Y; Nazmul Hasan M; Gu L; Li T
    Biochem Pharmacol; 2024 Apr; 222():116103. PubMed ID: 38428825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis.
    Xiang D; Yang J; Liu L; Yu H; Gong X; Liu D
    Biomed Pharmacother; 2023 Dec; 168():115606. PubMed ID: 37812893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioneer Factor Foxa2 Mediates Chromatin Conformation Changes for Activation of Bile Acid Targets of FXR.
    Hao Y; Han L; Wu A; Bochkis IM
    Cell Mol Gastroenterol Hepatol; 2024; 17(2):237-249. PubMed ID: 37879405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis.
    Tschuck J; Theilacker L; Rothenaigner I; Weiß SAI; Akdogan B; Lam VT; Müller C; Graf R; Brandner S; Pütz C; Rieder T; Schmitt-Kopplin P; Vincendeau M; Zischka H; Schorpp K; Hadian K
    Nat Commun; 2023 Oct; 14(1):6908. PubMed ID: 37903763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR.
    Ay Ü; Leníček M; Haider RS; Classen A; van Eijk H; Koelfat KVK; van der Kroft G; Neumann UP; Hoffmann C; Bolm C; Olde Damink SWM; Schaap FG
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38517202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic roles of FXR in liver and colorectal cancers.
    Huang X; Fan M; Huang W
    Mol Cell Endocrinol; 2022 Mar; 543():111543. PubMed ID: 34995680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor in chronic liver diseases: an immunohistochemical study.
    Sweed D; Holah NS; Karman E; Asaad N; Mahmoud S
    J Immunoassay Immunochem; 2023 Nov; 44(5-6):381-395. PubMed ID: 37665366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring FXR Modulators for Intestinal Specificity: Recent Progress and Insights.
    Morrison A; Elgendy B
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor represses human sulfotransferase 1A3 expression through direct binding to the promoter.
    Dou Y; Pei S; Li Y; Wang M; Liu Z; Li J; Cao J; Qin J; Zhang M; Hou L; Sun H
    Chem Biol Drug Des; 2023 Nov; 102(5):1014-1023. PubMed ID: 37487659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine particulate matter disrupts bile acid homeostasis in hepatocytes via binding to and activating farnesoid X receptor.
    Zhang D; Liu X; Sun L; Li D; Du J; Yang H; Yu D; Li C
    Toxicology; 2024 May; ():153850. PubMed ID: 38821196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of primary hepatocytes with adenoviral vectors alters biliary lipid metabolism.
    Rueda Y; Garcia-Arcos I; Aspichueta P; Ochoa B; Palacios L; Fresnedo O
    J Physiol Sci; 2013 May; 63(3):225-9. PubMed ID: 23558863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy in Malnourished Mice Is Sexually Dimorphic and Regulated by Nutrient-Sensing Nuclear Receptors.
    Preidis GA; Soni KG; Suh JH; Halder T; Kim KH; Choi JM; Li F; Devaraj S; Conner ME; Coarfa C; Jung SY; Moore DD
    Hepatol Commun; 2020 Dec; 4(12):1835-1850. PubMed ID: 33305154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR Friend-ChIPs in the Enterohepatic System.
    Meadows V; Yang Z; Basaly V; Guo GL
    Semin Liver Dis; 2023 Aug; 43(3):267-278. PubMed ID: 37442156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.